Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Attached to lymphokine – cytokine – or other secreted growth...
Reexamination Certificate
2007-03-20
2007-03-20
Russel, Jeffrey Edwin (Department: 1654)
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Attached to lymphokine, cytokine, or other secreted growth...
C514S011400, C530S311000
Reexamination Certificate
active
10486310
ABSTRACT:
In one embodiment, a composition of somatostatin analogues having the general formula:is provided wherein Z may be absent or present and when present is selected from DOTA- and DTPA-based chelators, NOTA-based chelators, carbonyl compounds, hydrazino nicotinamide, N4-chelators, desferrioxamine, NxSy-chelators, optionally complexed or labeled with a radioisotope, tyrosine for halogenation, a fluorescent dye, or biotin. The composition further provides that L may or may not be present and when present is a linker molecule, X1 is glutamic acid or a symmetric or asymmetric diamino acid containing 3 or 4 consecutive C atoms, X2 is a positively charged natural or unnatural amino acid, an arginine mimic, citrulline, or a neutral amino acid, X3 is phenylalanine, Ala-[3-(2-thienyl)], α-naphthylalanine, or β-naphthylalanine, X4 is an aromatic amino acid, X5 is threonine or serine, and X6 is phenylalanine, Ala-[3-(2-thienyl)], α-naphthylalanine, or β-naphthylalanine.
REFERENCES:
patent: 4261885 (1981-04-01), Sakakibara et al.
patent: 6930088 (2005-08-01), Hornik et al.
International Search Report, Based on PCT/EP02/09004, Dated Nov. 29, 2002.
Scicinski, J. J., et al., “The solid phase synthesis of a series of tri-substituted hydantoin ligands for the somatostatin SST5 receptor,” Bioorganic & Medicinal Chemistry Letters, Oxford, GB, vol. 8, No. 24, Dec. 15, 1998, pp. 3609-3614, XP004150376.
Reubi, J. C., et al., “A selective analog for the somatostatin SST1-receptor surtype expressed by human tumors,” European Journal of Pharmacology, Amsterdam, NL, Mar. 12, 1998, pp. 103-110, XP000876543.
Hoyer, D., et al., “Classification and nomenclature of somatostatin receptors,” Trends in Pharmacological Sciences, Elsevier Trends Journal, Cambridge, GB, vol. 16, No. 3, Mar. 1995, pp. 86-88, XP004207465.
Eisenwiener Klaus-Peter
Maecke Helmut Robert
Reubi Jean Claude
Rink Hans
Patterson & Sheridan L.L.P.
Russel Jeffrey Edwin
University of Bern
LandOfFree
Compositions of somatostatin analogues does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions of somatostatin analogues, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions of somatostatin analogues will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3785608